Pharma Journalist -

Grace Science, LLC announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to GS-100, an investigational AAV9 gene replacement therapy for the…
Read More...

SMi Group reports: Speakers confirmed for the 2nd annual Wearable Injectors and Connected Devices Conference 2021 which will convene 18th – 19th October. The Wearable Injectors and…
Read More...

SMi Reports: Exploring therapeutic applications of connected on-body devices at Inaugural Medical Wearables for Biosensors Conference Boston, USA. As part of SMi’s leading series of…
Read More...

Biotage is pleased to announce the launch of Biotage PhyPrep, a new automated platform for plasmid DNA purification that releases laboratory staff from the tedium of repetitive, manual…
Read More...

Arrowhead Pharmaceuticals Inc. and Horizon Therapeutics plc announced a global collaboration and license agreement for ARO-XDH, a previously undisclosed discovery-stage investigational…
Read More...

Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a…
Read More...

Tonix Pharmaceuticals Holding Corp. announced it plans to develop TNX-102 SL (cyclobenzaprine HCl sublingual tablets) as a potential treatment for Long COVID Syndrome (Long COVID) which…
Read More...

QIAGEN announced the launch of QIAprep&amp CRISPR Kit and CRISPR Q-Primer Solutions that allow researchers to analyze edited genetic material with unparalleled speed and efficiency…
Read More...

On June 9, 2021, Frontera Therapeutics Co., Ltd. ('Frontera') held a groundbreaking ceremony to start the construction of its Suzhou facility in bioBAY of Suzhou Industrial Park (SIP), …
Read More...

Nanjing Bioheng Biotech Co., Ltd. Announced UCAR T cell therapy product targeting CD7, code CTD401, received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration…
Read More...